Talk to us

Your feedback directly shapes Sporos.

VA HB 2757: Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report. | Sporos

VABetaHB 2757billBillPassed First Chamber

Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report.

Department of Medical Assistance Services; sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes; report. Directs the Department of Medical Assistance Services to determine the feasibility of participating in an optional Medicaid benefit for sickle cell disease and establishing Medicaid Health Homes to coordinate care and provide treatment for individuals with sickle cell disease. The bill requires the Department to report its findings in its annual review of sickle cell disease treatment and submit such review to the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health and the Joint Commission on Health Care by November 15, 2025. This bill is a recommendation of the Joint Commission on Health Care.

Introduced

Jan 17, 2025

Last Action

Feb 17, 2025

Session

VA 2025

AI Summary

Get a plain-English explanation of what this bill does, who it affects, and why it matters.

Passed by indefinitely in Finance and Appropriations (14-Y 0-N)

Candi Mundon King

←

SB 758

Previous Bill

SR 263

Next Bill

→

Talk to us

Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report.

AI Summary

Status

Sponsor